Insider Transactions in Q1 2024 at Enanta Pharmaceuticals Inc (ENTA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2024
|
Nathaniel S. Gardiner Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,187
+6.41%
|
$41,496
$8.99 P/Share
|
|
Feb 12
2024
|
Tara Lynn Kieffer Chief Product Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
973
-2.4%
|
$11,676
$12.41 P/Share
|
|
Feb 12
2024
|
Tara Lynn Kieffer Chief Product Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,320
+7.56%
|
-
|
|
Feb 12
2024
|
Brendan Luu Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
973
-2.43%
|
$11,676
$12.41 P/Share
|
|
Feb 12
2024
|
Brendan Luu Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,320
+7.65%
|
-
|
|
Feb 12
2024
|
Scott T. Rottinghaus Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
755
-2.6%
|
$9,060
$12.41 P/Share
|
|
Feb 12
2024
|
Scott T. Rottinghaus Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,576
+8.15%
|
-
|
|
Feb 12
2024
|
Nathaniel S. Gardiner Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
973
-1.36%
|
$11,676
$12.41 P/Share
|
|
Feb 12
2024
|
Nathaniel S. Gardiner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,320
+4.44%
|
-
|
|
Feb 12
2024
|
Yat Sun Or Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,080
-0.29%
|
$12,960
$12.41 P/Share
|
|
Feb 12
2024
|
Yat Sun Or Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,680
+0.97%
|
-
|
|
Feb 12
2024
|
Paul J Mellett Chief Fin. & Admin Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
973
-1.0%
|
$11,676
$12.41 P/Share
|
|
Feb 12
2024
|
Paul J Mellett Chief Fin. & Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,320
+3.31%
|
-
|
|
Feb 12
2024
|
Jay R. Luly President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,584
-0.2%
|
$19,008
$12.41 P/Share
|
|
Feb 12
2024
|
Jay R. Luly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,400
+0.66%
|
-
|